Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines seeks a Principal Regulatory Medical Writer to lead regulatory documentation across Europe for clinical development and marketing authorization in oncology. You will author, coordinate and finalize regulatory documents, ensuring compliance with ICH, EMA guidance and